natacha bohin
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Google:
"natacha bohin"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bohin N, Keeley TM, Carulli AJ, et al. (2020) Rapid Crypt Cell Remodeling Regenerates the Intestinal Stem Cell Niche after Notch Inhibition. Stem Cell Reports |
| Bohin N, McGowan KP, Keeley TM, et al. (2020) Insulin-like Growth Factor-1 and mTORC1 Signaling Promote the Intestinal Regenerative Response after Irradiation Injury. Cellular and Molecular Gastroenterology and Hepatology |
| Bohin N, Carlson EA, Samuelson LC. (2018) Genome Toxicity and Impaired Stem Cell Function after Conditional Activation of CreER in the Intestine. Stem Cell Reports. 11: 1337-1346 |
| Burgess MR, Hwang E, Firestone AJ, et al. (2014) Preclinical efficacy of MEK inhibition in Nras-mutant AML. Blood. 124: 3947-55 |
| Walczak EM, Kuick R, Finco I, et al. (2014) Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms. Molecular Endocrinology (Baltimore, Md.). 28: 1471-86 |
| Burgess MR, Hwang E, Firestone AJ, et al. (2014) Preclinical Efficacy of MEK Inhibition in Nras Mutant Acute Myeloid Leukemia Blood. 124: 3753-3753 |
| Li Q, Bohin N, Wen T, et al. (2013) Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness. Nature. 504: 143-7 |
| Li Q, Bohin N, Wen T, et al. (2012) Oncogenic Nras Increases Hematopoietic Stem Cell Proliferation and Self-Renewal Through a Bimodal Effect Blood. 120: 119-119 |
| Irwin ME, Bohin N, Boerner JL. (2011) Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells. Cancer Biology & Therapy. 12: 718-26 |
| Irwin ME, Mueller KL, Bohin N, et al. (2011) Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. Journal of Cellular Physiology. 226: 2316-28 |